Logo image
Recurrent Melioidosis in the Darwin Prospective Melioidosis Study: Improving Therapies Mean that Relapse Cases Are Now Rare
Journal article   Open access   Peer reviewed

Recurrent Melioidosis in the Darwin Prospective Melioidosis Study: Improving Therapies Mean that Relapse Cases Are Now Rare

Derek S Sarovich, L Ward, Erin P Price, M Mayo, M C Pitman, R W Baird and B J Currie
Journal of Clinical Microbiology, Vol.52(2), pp.650-653
2014
pdf
PDF - Published Version167.63 kBDownloadView
Published Version PDF - Published Version Open Access
url
https://doi.org/10.1128/JCM.02239-13View
Published Version

Abstract

The Darwin Prospective Melioidosis Study has documented 785 melioidosis cases over 23 years. Recurrent melioidosis occurred in 39/679 (5.7%) patients surviving initial infection; 29 patients suffered relapse of the original infection, and 10 presented with a new Burkholderia pseudomallei infection. With improved therapy, relapse has become rare in recent years. Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Microbiology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image